全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Elisabetta Abruzzese , Malgorzata Monika Trawinska ...
来源:[J].Journal of Hematology & Oncology(IF 4.458), 2016, Vol.9 (1), pp.1-3DOAJ
摘要:Abstract We studied telomere length in 32 CML patients who discontinued imatinib after achieving complete molecular remission and 32 age-sex-matched controls. The relative telomere length (RTL) was determined by q-PCR as the telomere to single copy gene (36B4) ratio normaliz...
作者:Elisabetta Abruzzese , Angelo M. Carella ...
来源:[J].Quality of Life Research(IF 2.412), 2018, Vol.27 (6), pp.1545-1554Springer
摘要:Abstract(#br) Purpose(#br)Myelofibrosis (MF) is a chronic myeloproliferative neoplasm characterised by an aggressive clinical course, with disabling symptoms and reduced survival. Patients experience a severely impaired quality of life and their families face the upheaval of...
作者:Elisabetta Abruzzese , Massimiliano Bonifacio ...
来源:[J].International Journal of Cardiology(IF 5.509), 2019Elsevier
摘要:Abstract(#br)Background(#br)Limited information is available regarding the rate of long-term cardiovascular (CV) mortality in chronic myeloid leukaemia (CML) patients treated with second- and third-generation tyrosine kinase inhibitors (2 ndG /3 rdG TKIs) in the real-life pr...
作者:Elisabetta Abruzzese , Francesco Buccisano ...
来源:[J].Annals of Hematology(IF 2.866), 2017, Vol.96 (3), pp.387-391Springer
摘要:Abstract(#br)Ruxolitinib, a JAK1 and JAK2 inhibitor, has been tested and approved for the treatment of primary and secondary myelofibrosis (MF). Aim of our study is to report safety and efficacy of ruxolitinib in 98 patients affected by MF treated outside clinical trials and...
作者:Pasquale Niscola , Fabio Efficace , Elisabetta Abruzzese
来源:[J].Supportive Care in Cancer(IF 2.649), 2018, Vol.26 (6), pp.1699-1701Springer
摘要:Abstract(#br)Current evidence, although limited, outlines that sexual dysfunction may represent a prominent part of the symptom burden experienced by the patients with hematologic malignancies (HM). However, despite their presumed negative effects on quality of life (QoL), s...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×